CSS
ITRM

Cubist Systematic Strategies’s Iterum Therapeutics ITRM Stock Holding History

Cubist Systematic Strategies’s Portfolio ITRM Stock Details ITRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-5,962
Closed -$207K – 3056
2021
Q2 		$207K Buy
+5,962
New +$129K ﹤0.01% 2541

Other funds holding ITRM

CPX
Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
GC
Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return

Cubist Systematic Strategies's ITRM Position: Q3 2021 in Review

Cubist Systematic Strategies sold out of Iterum Therapeutics (ITRM) in Q3 2021, closing a stake of 5,962 shares — an estimated $207K sold.

Cubist Systematic Strategies first reported a position in ITRM in Q2 2021 and held it in 1 quarter. The position peaked at $207K in Q2 2021. 42 funds tracked by Wall St. Rank hold ITRM as of Q3 2021.

  • Cubist Systematic Strategies reported no remaining Iterum Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Cubist Systematic Strategies sold 5,962 Iterum Therapeutics shares in Q3 2021, an estimated $207K.
  • Cubist Systematic Strategies first reported a position in Iterum Therapeutics in Q2 2021 and held it in 1 quarter.
  • Cubist Systematic Strategies's Iterum Therapeutics position peaked at $207K in Q2 2021.
  • 42 funds tracked by Wall St. Rank held Iterum Therapeutics as of Q3 2021.

Based on Cubist Systematic Strategies's 13F filing for Q3 2021, filed 15 Nov 2021.